Establishment of a quantitative bioanalytical method for an acetylcholinesterase inhibitor Ethyl 3-(2-(4-fluorophenyl) amino)-4-phenylthiazol-5-yl)-3-oxopropanoate including its physicochemical characterization and in vitro metabolite profiling using Liquid Chromatography-Mass Spectrometry

Add time:08/22/2019    Source:sciencedirect.com

Ethyl 3-(2-(4-fluorophenyl)amino)-4-phenylthiazo)-5-yl)-3-oxopropanoate is a novel molecule with potent acetylcholinesterase inhibition property. In this research, we have developed a rapid and selective RP-HPLC bioanalytical method for quantitative measurement of the molecule. The method has been validated following the USFDA bioanalytical method validation guideline. In addition, as a part of drug development, in vitro metabolite identification has also been performed. A Kromasil C18 column was used in eluting the molecule chromatographically. The optimized mobile phase was composed of a mixture of acetonitrile and 10 mM ammonium formate buffer (pH 4.6) in 70:30 ratio (v/v). The response of the molecule was found to be linear over a calibration range of 0.2 μg/mL to 12 μg/mL. The inter-day and intra-day accuracy of the method ranged from 89.95% to 101.90% and 99.84% to 104.08%, respectively. On the other hand, the precision (%CV) value for inter-day was in between 3.50% to 6.91% and for intra-day, it was 2.11% to 8.03%. The mean recovery of the molecule at three different quality control levels was more than 85%. The analyte was stable under different stability conditions including 12 h autosampler, 8 h bench top, 15 days long term at −20 °C and three freeze-thaw cycles. The method was applied to determine stability of the molecule in human plasma. The molecule was found to be stable with more than 90% remaining even after 120 min of incubation in plasma. Two metabolites each in rat liver microsome and human liver microsome has been identified.

We also recommend Trading Suppliers and Manufacturers of (E)-2-Fluoro-3-(4-fluorophenyl)-propenoic acid, ethyl ester (cas 111055-87-9). Pls Click Website Link as below: cas 111055-87-9 suppliers

Prev:Original ArticlesN-[11C]methylpiperidine esters as acetylcholinesterase substrates: an in vivo structure–reactivity study
Next:Enzymatic resolution of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate, an intermediate in the synthesis of (−)-Paroxetine)